Please provide your email address to receive an email when new articles are posted on . The FDA granted marketing approval to allow the Eversense E3 CGM to be integrated with insulin delivery systems.
The first fully implantable continuous glucose monitors can now be integrated with insulin pumps as part of an automated insulin delivery system As the first fully implantable device in the category, ...
The US Food and Drug Administration has designated the Eversense (Senseonics, Inc; Ascencia Diabetes Care) implanted continuous glucose monitor (CGM) as an "integrated CGM," meaning it can be used in ...
It is now more than 40 years since the first diabetic received an implantable insulin pump. Yet, the concept never took off, with Medtronic pulling the plug on R&D back in 2007. Now, a group of ...
Findings from a case series study revealed that 83% of 30 dietary supplements that were marketed online for weight loss had inaccurate ingredient labels. Additionally, some of the supplements ...
Implantable devices that release insulin into the body hold promise as an alternative way to treat diabetes without insulin injections or cannula insertions. However, one obstacle that has prevented ...
One promising approach to treating Type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can free patients from giving themselves frequent insulin injections ...
On 6 October 2020, the European Commission published guidance on the vigilance system for insulin infusion pumps and integrated meter systems. The guidance provides an illustrative table with examples ...
February 24, 2011 — The US Food and Drug Administration (FDA) has issued a Class I recall for certain lots of implantable infusion pumps manufactured by Medtronic, which are used in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback